Cesca Therapeutics Inc. (Nasdaq: KOOL) announced that it has entered into definitive subscription agreements with institutional investors to purchase 600,000 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE